Sorafenib as first-line treatment for patients with primary hepatocellular carcinoma: an outcome evaluation
Objective To evaluate the clinical outcomes following first-line treatment with sorafenib in patients with primary hepatocellular carcinoma (HCC). Methods This retrospective cohort study enrolled patients with primary HCC that had been treated with sorafenib. Their data were collected from the hospi...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2023-06-01
|
| Series: | Journal of International Medical Research |
| Online Access: | https://doi.org/10.1177/03000605231179928 |